When to boost? new trial seeks best COVID-19 shot timing for vulnerable patients
NCT ID NCT05415267
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at 320 adults who are about to start strong immune-suppressing therapy and have already had at least two COVID-19 shots. Researchers want to find out if giving a COVID-19 booster right before starting therapy or waiting six months provides better protection. Participants will also receive a diphtheria/tetanus booster to compare how the immune system responds to different vaccines.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- COVID-19 booster vaccine and diphtheria/tetanus toxoids vaccine
- What this could lead to
- If successful, this could help doctors choose the best time to give COVID-19 boosters to people starting immunosuppressive therapy, improving their protection against severe illness.
- What could go wrong
- This is a Phase 3 trial, but it focuses on timing rather than a new treatment. Results may not apply to all types of immunosuppression or vaccines, and individual responses may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Blacktown Hospital
RECRUITINGBlacktown, New South Wales, 2148, Australia
-
Concord General Repatriation Hospital
RECRUITINGConcord, New South Wales, 2137, Australia
-
Royal Prince Alfred Hospital
RECRUITINGCamperdown, New South Wales, 2050, Australia
-
St Vincent's Hospital, Sydney
RECRUITINGDarlinghurst, New South Wales, 2010, Australia
-
Westmead Hospital
RECRUITINGWestmead, New South Wales, 2145, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can specially trained immune cells flush out hidden HIV?
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Frailty check may steer safer cancer care for seniors